[Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia]
- PMID: 20187354
[Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia]
Abstract
Background: Schizophrenia is characterised by positive and negative symptoms as well as thought disorders and disorganised behaviour. Multiple cognitive deficits within the areas of memory, attention and executive functions are also associated with schizophrenia. Aim of the study was to proceed to a study of correlations between clinical dimensions of schizophrenia and cognitive functions.
Methods: The authors recruited 105 patients suffering from schizophrenia spectrum disorders (DSM IV criteria). The patients were clinically stabilised, showing no depressive state at the time of the study, with no organic brain disorders and no history of drug intake. They were clinically evaluated using the PANSS and the Calgary Depression Scale. A cognitive battery was also administered.
Results: Positive dimension of schizophrenia was shown to be independent from any cognitive function. Disorganisation was negatively correlated to attention, working memory, long-term verbal memory and executive functions. Negative dimension was negatively correlated with working memory and executive functions.
Conclusion: Cognition wasn't correlated to the positive dimension of schizophrenia whereas it was correlated to the negative and to the disorganisation dimension of the disease. This is probably due to overlapping of concepts.
Similar articles
-
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French.
-
Relationship between psychopathology and cognitive functioning in schizophrenia.Compr Psychiatry. 2004 Sep-Oct;45(5):392-400. doi: 10.1016/j.comppsych.2004.03.006. Compr Psychiatry. 2004. PMID: 15332203
-
Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.J Int Neuropsychol Soc. 2004 Jul;10(4):549-58. doi: 10.1017/S1355617704104074. J Int Neuropsychol Soc. 2004. PMID: 15327733
-
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].Encephale. 2001 Sep-Oct;27(5):405-15. Encephale. 2001. PMID: 11760690 Review. French.
-
Executive function in schizophrenia: what impact do antipsychotics have?Hum Psychopharmacol. 2007 Aug;22(6):397-406. doi: 10.1002/hup.861. Hum Psychopharmacol. 2007. PMID: 17579928 Review.
Cited by
-
Effects of modified electroconvulsive therapy on the cognitive function and blood parameters in female patients with schizophrenia.Int J Clin Exp Med. 2015 Jan 15;8(1):1349-55. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25785136 Free PMC article.
-
The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.Schizophr Res Cogn. 2021 Feb 25;24:100195. doi: 10.1016/j.scog.2021.100195. eCollection 2021 Jun. Schizophr Res Cogn. 2021. PMID: 33718008 Free PMC article.
-
ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway.J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):491-495. doi: 10.1007/s11596-017-1762-4. Epub 2017 Aug 8. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 28786073
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources